Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
687
datasets available to search
ShareScore release 0.9.0
Dataset results
687 results for “MDS”
T-cell Depleted Donor Lymphocyte Infusion (DLI)for Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00242515. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Panobinostat Maintenance After HSCT fo High-risk AML and MDS
ClinicalTrials.gov study NCT04326764. IPD Sharing: Not stated. Countries: 2. Publications: 0.
RIC Regimen for Low- and Intermediate-risk MDS Receiving Haplo-HSCT
ClinicalTrials.gov study NCT03412266. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluating Low-dose Deferasirox (DFX) in Patients With Low-risk MDS Resistant or Relapsing After ESA Agents
ClinicalTrials.gov study NCT03387475. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of Bisantrene Combined With Cytarabine or With Decitabine for Adult Subjects With Extramedullary AML and MDS
ClinicalTrials.gov study NCT05456269. IPD Sharing: NO. Countries: 1. Publications: 0.
Azacytidine and Lymphocytes in Relapse of AML or MDS After Allogeneic Stem Cell Transplantation.
ClinicalTrials.gov study NCT02017457. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Allo Transplantation With Mylotarg, Fludarabine and Melphalan for AML, CML and MDS
ClinicalTrials.gov study NCT00038831. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Peptide Vaccination in Combination With Azacitidine for Patients With MDS and AML
ClinicalTrials.gov study NCT02750995. IPD Sharing: YES. Countries: 1. Publications: 0.
Study of Azacitidine With or Without Birinapant in Subjects With MDS or CMMoL
ClinicalTrials.gov study NCT02147873. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Low-dose AZA Combined With Short Term CAG Derived Regimen as a Bridging Treatment in Patients With Advanced MDS Prior to Allo-HSCT
ClinicalTrials.gov study NCT04216355. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Jaktinib and Azacitidine In Treating Patients With MDS With MF or MDS/MPN With MF.
ClinicalTrials.gov study NCT04866056. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT05143996. IPD Sharing: NO. Countries: 1. Publications: 0.
A Clinical Study of 6MW3211 Monotherapy or Combination Therapy for AML or MDS
ClinicalTrials.gov study NCT05448599. IPD Sharing: NO. Countries: 1. Publications: 0.
ELEMENT-MDS: A Study to Compare the Efficacy and Safety of Luspatercept in Participants With Myelodysplastic Syndrome (MDS) and Anemia Not Receiving Blood Transfusions
ClinicalTrials.gov study NCT05949684. IPD Sharing: YES. Countries: 21. Publications: 0.
Understanding Mechanisms of Synaptic Degeneration Underlying Clinical Symptoms in Patients With MDs and NDs.
ClinicalTrials.gov study NCT07234851. IPD Sharing: YES. Countries: 1. Publications: 0.
AML-MDS Novel Prognostic Tests Clinical Study
ClinicalTrials.gov study NCT01685619. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy Study of CHG Regimen vs Decitabine to Treat Higher-risk MDS
ClinicalTrials.gov study NCT01417767. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Investigate Fadraciclib (CYC065), in Subjects With Leukemia or Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT05168904. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase 2a Study of HT-6184 in Subjects With IPSS-R Very Low, Low or Intermediate Risk MDS and Anemia
ClinicalTrials.gov study NCT07052006. IPD Sharing: NO. Countries: 1. Publications: 0.
Health Outcomes of Recently Diagnosed Myelodysplastic Syndrome (MDS)/Chronic Myelomonocytic Leukemia (CMML) Patients Depending on Treatment Strategy (Wait and See, Support, Active Treatment)
ClinicalTrials.gov study NCT02085798. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.